Skip to main content
Rizobacter Argentina S.A. logo

Rizobacter Argentina S.A. — Investor Relations & Filings

ISIN · AR0065093756 BYMA Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2020-11-11 Regulatory Filings
Country AR Argentina
Listing BYMA

About Rizobacter Argentina S.A.

https://rizobacter.com.ar/en/argentina

Rizobacter is a leading agricultural biosolutions company that researches, develops, and commercializes innovative products for sustainable crop growth. Specializing in biologicals, its comprehensive portfolio includes inoculants, biostimulants, seed treatments, adjuvants, biocontrol agents, and crop nutrition solutions. Notably, Rizobacter is a global leader in soybean inoculants. The company's sustainable biological solutions enhance crop productivity, drive higher yields, and contribute to global food security, leveraging a unique biotech platform with patented technologies for microbial ag-inputs.

Recent filings

Filing Released Lang Actions
PROGRAMA: RES Nº17,737 - 40,000,000 - SERIE :SERIE LL /CLASE A DÓLAR - AVISO DE PAGO OBLIGACIONES NEGOCIABLES
Regulatory Filings
2020-11-11 Spanish
FEC. CELEB.: 27-10-2020 - APRUEBA EECC: SI - ACTA DE ASAMBLEA Y/O REUNIÓN DE SOCIOS03
Regulatory Filings
2020-11-03 Spanish
FEC. CELEB.: 27-10-2020 - APRUEBA EECC: SI - ACTA DE ASAMBLEA Y/O REUNIÓN DE SOCIOS03
AGM Information Classification · 95% confidence The document is a detailed record of an Annual General Meeting (AGM) of Rizobacter Argentina S.A. held on October 27, 2020. It includes the agenda, discussions, voting results, and mentions of financial statements for the fiscal year ended June 30, 2020. The text is an official meeting minute (acta) covering the proceedings of the AGM, including shareholder participation, approval of management and fiscal commission, remuneration considerations, and other corporate governance matters. This matches the description of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document is lengthy (15,000 characters) and contains substantive content from the meeting itself, not just an announcement or summary. Therefore, the correct classification is AGM Information (AGM-R).
2020-10-28 Spanish
INFORMACIÓN SOCIETARIA - HECHO RELEVANTE - CAMBIO DE OBJETO SOCIAL - HECHO RELEVANTE
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to regulatory bodies and stock exchanges in Argentina, reporting a resolution passed at the Ordinary and Extraordinary General Shareholders' Meeting held on October 27, 2020. The resolution concerns a modification of the company's corporate purpose to include the ability to grant guarantees and sureties to third parties. The document is short (1146 characters) and serves as an official announcement of a corporate action decided at a shareholders' meeting. It is not a full report, financial statement, or detailed presentation. It is not a voting result declaration but rather a regulatory announcement of a corporate change decided at a shareholders' meeting. Given the nature of the content and the regulatory context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-27 Spanish
FEC. CELEB.: 08-10-2020 - TEMA: TEMAS VARIOS - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Capital/Financing Update Classification · 95% confidence The document is a formal meeting record (Acta) of the Board of Directors of Rizobacter Argentina S.A. It details the approval of the use of funds from a bond issuance (Obligaciones Negociables Serie III). The content focuses on the declaration and approval of the application of funds raised through a financing activity. There are no financial statements or detailed financial performance data, nor is it a full annual or interim report. It is not a simple announcement or publication notice but a record of a board meeting decision related to capital use. This fits best under Capital/Financing Update (CAP), as it concerns the allocation of proceeds from a financing instrument.
2020-10-14 Spanish
FECHA DOC.: 09-10-2020 - REMUNERACIONES AL DIRECTORIO - REMUNERACIONES GLOBALES DEL DIRECTORIO
Remuneration Information Classification · 95% confidence The document is a letter addressed to the Comisión Nacional de Valores (National Securities Commission) reporting on the allocations to the members of the Board of Directors of Rizobacter Argentina S.A. based on the annual financial statements as of June 30, 2020. It includes specific financial figures related to director compensation, dividends, net income, and reserves. The document is short (1227 characters) and does not contain full financial statements or comprehensive financial analysis. It is a regulatory communication about director remuneration derived from annual financial results, but it is not the full Annual Report or Audit Report itself. Given the focus on director allocations and compensation, this fits best under Remuneration Information (DEF 14A).
2020-10-09 Spanish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.